Market Closed -
NSE India S.E.
07:43:48 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
372.2
INR
|
-1.55%
|
|
+4.71%
|
-6.53%
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
12,575
|
15,556
|
9,061
|
14,047
|
25,381
|
14,703
|
Enterprise Value (EV)
1 |
14,187
|
16,987
|
10,418
|
15,443
|
26,169
|
14,228
|
P/E ratio
|
3.33
x
|
9.48
x
|
2.35
x
|
5.56
x
|
6.53
x
|
13.8
x
|
Yield
|
-
|
0.4%
|
0.19%
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.13
x
|
1.12
x
|
0.69
x
|
1.47
x
|
1.7
x
|
1.56
x
|
EV / Revenue
|
1.27
x
|
1.22
x
|
0.8
x
|
1.61
x
|
1.75
x
|
1.51
x
|
EV / EBITDA
|
7.75
x
|
7.27
x
|
5.53
x
|
18.2
x
|
21.4
x
|
-44.9
x
|
EV / FCF
|
-25.2
x
|
27
x
|
-88.1
x
|
339
x
|
35.5
x
|
8.64
x
|
FCF Yield
|
-3.96%
|
3.71%
|
-1.14%
|
0.3%
|
2.82%
|
11.6%
|
Price to Book
|
0.9
x
|
0.99
x
|
0.47
x
|
0.64
x
|
0.99
x
|
0.55
x
|
Nbr of stocks (in thousands)
|
30,244
|
31,344
|
33,621
|
33,621
|
51,834
|
51,834
|
Reference price
2 |
415.8
|
496.3
|
269.5
|
417.8
|
489.6
|
283.6
|
Announcement Date
|
8/29/18
|
9/3/19
|
9/1/20
|
9/3/21
|
9/3/22
|
9/1/23
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
11,169
|
13,938
|
13,054
|
9,570
|
14,969
|
9,451
|
EBITDA
1 |
1,832
|
2,336
|
1,883
|
850.4
|
1,224
|
-317.1
|
EBIT
1 |
1,492
|
1,961
|
1,439
|
389.4
|
723
|
-805.8
|
Operating Margin
|
13.36%
|
14.07%
|
11.03%
|
4.07%
|
4.83%
|
-8.53%
|
Earnings before Tax (EBT)
1 |
3,763
|
1,975
|
4,019
|
2,654
|
4,042
|
1,223
|
Net income
1 |
3,580
|
1,641
|
3,755
|
2,525
|
3,888
|
1,067
|
Net margin
|
32.05%
|
11.77%
|
28.77%
|
26.38%
|
25.97%
|
11.29%
|
EPS
2 |
124.9
|
52.36
|
114.5
|
75.10
|
75.00
|
20.58
|
Free Cash Flow
1 |
-562.2
|
630
|
-118.3
|
45.59
|
736.7
|
1,648
|
FCF margin
|
-5.03%
|
4.52%
|
-0.91%
|
0.48%
|
4.92%
|
17.43%
|
FCF Conversion (EBITDA)
|
-
|
26.97%
|
-
|
5.36%
|
60.17%
|
-
|
FCF Conversion (Net income)
|
-
|
38.39%
|
-
|
1.81%
|
18.95%
|
154.48%
|
Dividend per Share
|
-
|
2.000
|
0.5000
|
-
|
-
|
-
|
Announcement Date
|
8/29/18
|
9/3/19
|
9/1/20
|
9/3/21
|
9/3/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,612
|
1,431
|
1,357
|
1,396
|
789
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
475
|
Leverage (Debt/EBITDA)
|
0.8801
x
|
0.6128
x
|
0.7206
x
|
1.641
x
|
0.6441
x
|
-
|
Free Cash Flow
1 |
-562
|
630
|
-118
|
45.6
|
737
|
1,648
|
ROE (net income / shareholders' equity)
|
29.4%
|
11%
|
21.5%
|
12.3%
|
16.3%
|
4.06%
|
ROA (Net income/ Total Assets)
|
5.65%
|
6.31%
|
4.03%
|
0.95%
|
1.57%
|
-1.61%
|
Assets
1 |
63,382
|
25,994
|
93,126
|
264,732
|
248,386
|
-66,454
|
Book Value Per Share
2 |
464.0
|
500.0
|
575.0
|
650.0
|
496.0
|
517.0
|
Cash Flow per Share
2 |
4.130
|
6.100
|
3.720
|
2.250
|
2.580
|
5.330
|
Capex
1 |
657
|
1,154
|
1,131
|
778
|
375
|
222
|
Capex / Sales
|
5.88%
|
8.28%
|
8.66%
|
8.13%
|
2.5%
|
2.35%
|
Announcement Date
|
8/29/18
|
9/3/19
|
9/1/20
|
9/3/21
|
9/3/22
|
9/1/23
|
|
1st Jan change
|
Capi.
|
---|
| +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|